z-logo
Premium
P4‐299: A Computational Method to Predict Disease‐Specific Epitopes in Aβ, and its Application to Oligomer‐Selective Antibodies for Alzheimer’S Immunotherapy
Author(s) -
Plotkin Steven S.,
Peng Xubiao,
Silverman Judith M.,
Cashman Neil R.
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.07.042
Subject(s) - oligomer , epitope , context (archaeology) , chemistry , molecular dynamics , proteostasis , neurodegeneration , conformational ensembles , protein folding , biophysics , dihedral angle , protein structure , computational biology , antibody , biology , biochemistry , computational chemistry , disease , molecule , immunology , medicine , paleontology , hydrogen bond , organic chemistry , pathology
in Alzheimer’s disease (AD) is truncated at the N-terminus. Among these, accumulation of pGlu-modified amyloid (pGlu-Ab3-40/42) has been shown to correlate with disease progression and tau pathology. Therapeutic strategies targeting pGlu-Ab, e.g. inhibitors of glutaminyl cyclase (QC) that catalyzes pGlu-formation, are currently in clinical assessment. However, it is still unclear, which enzyme(s) might be responsible for N-truncation of Ab and thus, generation of QC substrates. Aim of the study was to characterize the potential formation of the precursor(s) of pGlu-Ab3-40/42 by Meprin b in cell culture.Methods:We expressed different APP proteins (wt or familial Alzheimer’s mutations) in the cell lines HEK293 and CHO. The APP processing and production was assessed using Western Blot analysis and ELISAs detecting N-truncated or full length Ab. Maldi-TOF mass spectrometry was used to analyze cleavage of APP-derived peptides. Results:An in vitro analysis of cleavage of APP-related peptides suggested specificity of Meprin b for the b-site of APP. The primary cleavage products were Ab(1-x), Ab(2-x) and, to a lesser extent, Ab(3-x). In cell culture, co-expression of APP and Meprin b, but not of its isoenzyme Meprin a, resulted in production of N-truncated Ab peptides, primarily Ab(2-40/42). Thereby, Meprin b cleaved preferably APPwt and not APPswedish, which contrasts to the b-secretase BACE. The cleavage of APP resulted also in minor amounts of Ab(3-40/42), which was revealed by addition of human QC and application of highly sensitive ELISA detecting pGlu-Ab3-40/42. Finally, analysis of human brain samples revealed upregulation of Meprin b, but not Meprin a, in AD. Meprin b positive astrocytes are found in the vicinity of pGlu-Ab containing deposits in human tissue. Conclusions: The data support a BACE-independent processing of APPwt that may contribute to formation of N-truncated Ab. These truncated forms, in turn, might be prone to further post-translational modification. Thus, Meprin b might represent a potential upstream target to suppress formation of pGlu-Ab.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom